AstraZeneca increasing investments to EGP 400 mn, implying new investment of EGP 100 mn

AstraZeneca Egypt are increasing their investments to EGP 400 mn this year, country President Khaled Atef told Al Borsa. The company is launching a new med for hypertension and heart disease, he added. We had reported last year that AstraZeneca had invested EGP 300 mn in the domestic market.